YOLFTbeta
Ortoma AB Series B

Ortoma AB Series B

ORT-B · ST · Healthcare / Medical Devices

10.46SEK-0.06 (-0.57%)

Price History

Full chart

Market Stats

Previous Close10.52
Open10.48
Day Range10.38 – 10.54
52-Week Range6.81 – 19.65
Volume13.54K
Market Cap334.52M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.68
Dividend Yield0.00%
Beta0.84
50-Day Avg7.62
200-Day Avg9.41

About

Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; and OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position. The company was founded in 2001 and is based in Gothenburg, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOFredrik Stromberg
  • Employees18
  • HeadquartersFalkenbergsgatan 3, Gothenburg, Sweden, 412 85, Sweden
  • Websitehttps://www.ortoma.com

Leadership

  • Fredrik StrombergChief Executive Officer
  • Anna ZylaHead of Operations
  • Carianne NilssonHead of Sales & Marketing
  • Dr. Andreas Pettersson Ph.D.Head of Clinical Operations
  • Hassan NematiHead of Technical Research
  • Fredrik HedbergHead of QA/RA

Financials

Income Statement

Currency: SEK2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue0038.14M49.11M64.64M
Growth (%)---+28.77%+31.61%
Cost of Revenue-20.00M-23.37M-17.83M166.87K10.95M
Gross Profit20.00M23.37M55.97M48.95M53.69M
Gross Margin--146.75%99.66%83.06%
Operating Expense33.35M38.36M53.86M63.52M73.20M
Operating Income-13.35M-14.99M2.11M-14.58M-19.51M
Operating Margin--5.54%-29.68%-30.19%
EBITDA--14.87M-15.16M587.83K-4.35M
EBITDA Margin---39.74%1.20%-6.73%
Net Income-10.79M-15.75M-21.87M-11.63M-19.19M
Net Income Margin---57.35%-23.68%-29.69%
Interest Expense696775.60K560.59K3.88K6.97K
Interest Expense % of Total Revenue--1.47%0.01%0.01%

Balance Sheet

Currency: SEK2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets133.99M151.31M192.33M180.98M161.34M
Total Liabilities3.95M37.02M18.80M19.07M18.63M
Total Equity130.04M114.29M173.54M161.91M142.72M
Cash12.63M8.11M51.44M17.82M20.77M

Cash Flow

Currency: SEK2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-15.19M-8.29M13.35M-22.01M6.04M
Capital Expenditure20.24M23.44M23.94M11.61M3.09M
Free Cash Flow-35.43M-31.72M-10.59M-33.62M2.95M
FCF to OCF233.23%382.81%-79.30%152.75%48.90%

Earnings

Report DateDec 31, 2015Mar 31, 2016Jun 30, 2016Dec 31, 2016Mar 31, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Aug 15, 2025Nov 14, 2025Feb 26, 2026May 21, 2026Jul 30, 2026
EPS Estimate--------------------------------------0.33-0.45
EPS Actual-0.04-0.10-0.10-0.12-0.11-0.12-0.10-0.14-0.19-0.06-0.08-0.09-0.20-0.14-0.18-0.12-0.11-0.13-0.13-0.13-0.17-0.20-0.04-0.15-0.19-0.190.40-0.06-0.75-0.150.14-0.02-0.280.430.03-0.38-0.58-0.22-0.47
Surprise-------------------------------------33.33%-4.44%
Timing-------------------------------------Pre-marketPre-market

Key Statistics & Ratios

Market Cap334.52M
Enterprise Value268.25M
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.87
Price / Book2.05
EPS-1.68
Book Value3.72
Revenue (TTM)33.90M
Gross Profit (TTM)-26.29M
EBITDA-64.19M
Profit Margin-194.47%
Operating Margin-204.26%
Return on Equity-37.29%
Return on Assets-21.16%
Shares Outstanding45.12M
Shares Float42.72M
Beta0.84
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%